Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Nov 1 LDOS Surging Earnings Estimates Signal Upside for Leidos (LDOS) Stock
Nov 1 GMED CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
Nov 1 LDOS Best Momentum Stock to Buy for November 1st
Nov 1 LDOS Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Nov 1 GMED Boston Scientific Stock Gains From Market Expansion, Innovation
Nov 1 LDOS Now is the Time to Accumulate 5 Relative Price Strength Stocks
Nov 1 TGTX TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
Nov 1 GMED PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis
Nov 1 LDOS Play Likely Earnings Beat With 4 Top-Ranked Stocks
Nov 1 LDOS New Strong Buy Stocks for November 1st
Oct 31 TGTX Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025?
Oct 31 GMED Gear Up for Globus Medical (GMED) Q3 Earnings: Wall Street Estimates for Key Metrics
Oct 31 GMED CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View
Oct 31 LDOS Leidos awarded Organ Procurement and Transplantation Network operations contract
Oct 31 IFRX InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference
Oct 31 LDOS Leidos Holdings (NYSE:LDOS) Is Increasing Its Dividend To $0.40
Oct 30 LDOS Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific
Oct 30 AUPH Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024
Oct 30 GMED GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
Oct 30 QURE Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags